Builds privacy technology around the Zcash network and develops antibody therapies for patients with cancer through its Leap subsidiary.
10-K for FY2025, filed Mar 16, 2026We are a privacy technology company implementing a digital asset treasury strategy anchored by Zcash and, through our subsidiary Leap, are…View ↗
We are not a typical digital asset treasury company. While we hold digital assets as part of our strategy, our core business is…View ↗
Our subsidiary, Leap, is a biopharmaceutical company developing novel biomarker-targeted antibody therapies designed to treat patients with…View ↗
8-K, filed Aug 18, 2026
Pursuant to the APA, the Buyer agreed (i) to purchase and acquire from the Seller certain assets and rights (collectively, the “Purchased…View ↗
From cancer drug development to privacy technology
The older report described a biopharmaceutical business developing antibody therapies for cancer. The latest report adds a privacy technology strategy centered on Zcash, digital asset holdings and privacy-focused investments, while continuing cancer drug development through Leap.
10-K for FY2022, filed Mar 24, 2023 10-K for FY2025, filed Mar 16, 2026We are a biopharmaceutical company developing novel biomarker-targeted antibody therapies designed to treat patients with cancer by…View ↗
We are a privacy technology company implementing a digital asset treasury strategy anchored by Zcash and, through our subsidiary Leap, are…View ↗
We are not a typical digital asset treasury company. While we hold digital assets as part of our strategy, our core business is…View ↗
Our subsidiary, Leap, is a biopharmaceutical company developing novel biomarker-targeted antibody therapies designed to treat patients with…View ↗
Competes with Grayscale Zcash Trust, Strategy, and a16z crypto
10-K for FY2025, filed Mar 16, 2026The privacy technology, cryptocurrency, and digital asset treasury industries are characterized by continuing technological advancement and…View ↗
Loading...